Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Refractory neurogenic detrusor overactivity.

F Cruz1, C Silva

  • 1Department of Urology, Hospital São João and Faculty of Medicine of Porto, Porto, Portugal. cruzfjmr@med.up.pt

International Journal of Clinical Practice. Supplement
|December 16, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Final overall survival results from EORTC 1333/PEACE-3 trial of enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Author Correction: Tree diversity is changing across tropical Andean and Amazonian forests in response to global change.

Nature ecology & evolution·2026
Same author

Tree diversity is changing across tropical Andean and Amazonian forests in response to global change.

Nature ecology & evolution·2026
Same author

Corrigendum to "Towards targeted cancer therapy: synthesis, characterization, and biological activity of a new Cu(II)-ibuprofen-2,2'-dipyridylamine metal complex" [Heliyon Volume 11, Issue 1, January 2025, Article e41323].

Heliyon·2025
Same author

First Constraint on Atmospheric Millicharged Particles with the LUX-ZEPLIN Experiment.

Physical review letters·2025
Same author

New Constraints on Cosmic Ray-Boosted Dark Matter from the LUX-ZEPLIN Experiment.

Physical review letters·2025

Refractory neurogenic detrusor overactivity (NDO) is difficult to manage after anticholinergic therapy fails. Treatment options range from injections and instillations to surgery for better outcomes.

Area of Science:

  • Urology
  • Neuroscience

Background:

  • Refractory neurogenic detrusor overactivity (NDO) presents significant challenges in managing urinary incontinence.
  • Protecting the upper urinary tract is difficult in patients with refractory NDO.

Purpose of the Study:

  • To outline treatment strategies for refractory neurogenic detrusor overactivity.
  • To discuss the efficacy and limitations of various NDO treatment options.

Main Methods:

  • Review of current therapeutic approaches for refractory NDO.
  • Analysis of treatment outcomes including botulinum toxin injections, vanilloid compounds, bladder augmentation, and sacral anterior root stimulation.

Main Results:

  • Anticholinergic therapy failure defines refractory NDO.

Related Experiment Videos

  • Botulinum toxin and resiniferatoxin offer alternatives to oral medications.
  • Bladder augmentation and sacral anterior root stimulation provide effective solutions when other methods fail.

    • Conclusions:

    • Effective management of refractory NDO requires a stepwise approach.
    • Advanced treatments like bladder augmentation and sacral anterior root stimulation yield excellent outcomes but involve higher risks and costs.